Protecting children from iatrogenic harm during COVID19 pandemic

J Paediatr Child Health. 2020 Jul;56(7):1010-1012. doi: 10.1111/jpc.14989. Epub 2020 Jun 22.

Abstract

Critical care management of patients with COVID-19 has been influenced by a mixture of public, media and societal pressure, as well as clinical and anecdotal observations from many prominent researchers and key opinion leaders. These factors may have affected the principles of evidence-based medicine and encouraged the widespread use of non-tested pharmacological and aggressive respiratory support therapies, even in intensive care units (ICUs). The COVID-19 pandemic has predominantly affected adult populations, while children appear to be relatively spared of severe disease. Notwithstanding, paediatric intensive care (PICU) clinicians may already have been influenced by changes in practices of adult ICUs, and these changes may pose unintended consequences to the vulnerable population in the PICU. In this article, we analyse several potential iatrogenic causes of the detrimental effects of the current pandemic to children and highlight the risks underlying a sudden change of clinical practice.

Keywords: Covid-19; coronavirus; paediatric intensive care; paediatrics; therapy.

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Child
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / therapy*
  • Critical Care
  • Critical Illness / therapy*
  • Evidence-Based Medicine*
  • Humans
  • Iatrogenic Disease / prevention & control*
  • Intensive Care Units, Pediatric
  • Medical Errors
  • Pandemics
  • Pediatrics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2